echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Immunology News > Immunol Rev: Long-life plasma cell formation is critical to vaccine efficacy!

    Immunol Rev: Long-life plasma cell formation is critical to vaccine efficacy!

    • Last Update: 2020-07-15
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    , July 5, 2020 /
    Biovalley
    BIOON/- Monash University has looked at the effects of plasma cells and their life span on vaccine effectiveness in the human body, and concluded that components in vaccine design are keyafter the outbreak of COVID-19, many studies have focused on the development of vaccinesThere are two things you have to do if vaccines are to succeedFirst, it must signal the body that it produces a large number of plasma cells to make antiviral antibodiesSecond, these plasma cells must survive and produce antibodies for years or even decades before the vaccine can be successfully vaccinatedThe reality, however, is that most of them can only survive for a few daysphoto source: Professor David Tarlinton of the Immune Memory Laboratory at Monash UniversityMonash University Center Clinical School recently published a study in the journal immunereview s at the, which suggests that ingredients in vaccines can play an important role in extending the life of individual slurry cellsUnderstanding the process of long-life plasma cell formation will provide a more effective method for vaccine productionOne of the difficulties ofdesigning an effective vaccine is that it is not clear what determines how long a single plasma cell will surviveWe have limited understanding of what makes pulp cells that survive longer and what keeps them alive during their developmentthe paper goes a step further in concept and outlines the potential for survival clues between plasma cells, so there may be a "survival of the fittest" long-term antibody immunityDr Marcus Robinson, a researcher at Monash University in 's Tarlinton lab, said the paper outlines a framework that can be used to identify a single signal that causes long-term antibody reactions in pulp cells "It's exciting that we're at the cutting edge of understanding this complex set of events that could be used in vaccine design in the near future," he said (BioValleyBioon.com) References: Unlocking the key to an effective vaccine
    Marcus J Robinson et al.
    How ar y extrinsic regulators of plasma cell survival o sy'n intersect for good ei , immunity i'r myso reviews (2020) DOI: 10.1111/imr.12895
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.